Invokana News

The FDA is alerting consumers that there is an Invokana amputation risk associated with the popular diabetes drug.  The FDA is now requiring a black box warning on the label so that consumers are aware of the foot and leg amputation risk. Invokana Amputation Following […]

According to the Institute for Safe Medication Practices (ISMP), an analysis of FDA adverse event data from 2015 revealed that more than 630 reports of ketoacidosis involving Invokana patients had been logged by the agency’s database that year. ISMP also noted that Invokana received more serious […]

Invokana was introduced to the U.S. market in March 2013 and quickly became the go-to type 2 diabetes treatment, although the safety of the medication became a point of contention relatively quickly. What is Invokana? Invokana is a SGLT2 inhibitor that is prescribed along with […]

Invokana side effects have garnered considerable attention in the U.S. as a result of several FDA safety warnings – one for diabetic ketoacidosis and one for an increased risk of leg and foot amputations. According to recent studies and Safety communications by both the FDA […]

Individuals who have been harmed by Invokana are currently filing Invokana Diabetic Ketoacidosis lawsuits against the manufacturer, Janssen, a division of Johnson & Johnson. Invokana lawsuits claim the manufacturer of the drug, Janssen/Johnson & Johnson knew about the risk of diabetic ketoacidosis but did not […]

The number of lawsuits brought against the maker of the diabetes drug Invokana continues to grow, with another Invokana lawsuit being filed on March 31, 2016, in the Superior Court of the State of Delaware. The plaintiff, a type 2 diabetes patient, claims that after […]